Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

A tie-up between a Chinese research institute and tech company said on Monday that it aims to implant its brain chip into 13 ...

Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell ...

A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, ...

Leqembi — sold through a partnership between Eisai Co. and Cambridge-based Biogen — is one of the first medications approved ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

ACESOT-1051 Trial Expanded to Include HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) Patients, Targeting Populations Most Likely to Benefit for WEEI InhibitionDOYLESTOWN, Pa., March 31, 2025 ...

In the past, if an NIH-funded clinical trial needed to halt—in an instance of, say, misconduct or clear harm to patients—the agency could be counted on to provide money and support to ensure ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Clinical trials are essential in bringing innovative treatments to the market, but managing them efficiently requires cutting-edge technology. This is where IRT clinical trial companies play a crucial ...